RetinalGenix Technologies

RetinalGenix Technologies Goodwill

Goodwill of RetinalGenix Technologies (RTGN) as of Oct 18, 2026.

Goodwill

-USD

Last updated:

Goodwill of RetinalGenix Technologies is 2026 - USD. Goodwill of RetinalGenix Technologies was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RetinalGenix Technologies Stock analysis

What does RetinalGenix Technologies do? RetinalGenix Technologies Inc, based in Petaluma, California, is a medical device company focused on ocular health. The company develops innovative solutions for screening, monitoring, diagnosing, and treating sight-threatening disorders, particularly diabetic retinopathy and maculopathy. Its key products include the Retinal Imaging Screening Device, a portable system offering a 200-degree field of view without pupil dilation, and RetinalCam, a home monitoring device with 24/7 physician access for real-time communication. Both devices aim to address vision loss and blindness through advanced imaging technology. RetinalGenix Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RetinalGenix Technologies stock

On Eulerpool you can find the complete historical development of Goodwill RetinalGenix Technologies since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's RetinalGenix Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RetinalGenix Technologies

All Key Metrics — RetinalGenix Technologies